Search Results - "Madji Hounoum, B."

Metabolomics in amyotrophic lateral sclerosis: how far can it take us? by Blasco, H., Patin, F., Madji Hounoum, B., Gordon, P. H., Vourc'h, P., Andres, C. R., Corcia, P.

“…Amyotrophic lateral sclerosis (ALS) is the most common adult‐onset motor neuron disease. Alongside identification of aetiologies, development of biomarkers is…”
Get full text

Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis by Patin, F., Corcia, P., Madji Hounoum, B., Veyrat-Durebex, C., Respaud, E., Piver, E., Benz-de Bretagne, I., Vourc'h, P., Andres, C. R., Blasco, H.

“…Background and purpose Amyotrophic lateral sclerosis (ALS) is a fatal disorder of the motor neuron system, with a median survival of 2 to 4 years and a wide…”
Get full text

Biomarkers in amyotrophic lateral sclerosis: combining metabolomic and clinical parameters to define disease progression by Blasco, H., Nadal-Desbarats, L., Pradat, P.-F., Gordon, P. H., Madji Hounoum, B., Patin, F., Veyrat-Durebex, C., Mavel, S., Beltran, S., Emond, P., Andres, C. R., Corcia, P.

“…Background and purpose The objectives of this study were to define the metabolomic profile of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS)…”
Get full text